{"name":"Vascular Insights, LLC","slug":"vascular-insights-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxPZVkteWE1dDUyMmdyUFYxbmR1TGN5WmJxSFpiQmx0bFJHcnJOY1BJMVNDWEdTZU9LOUdvbnpPaV9mcXRGVjJ0NTdNS0VjVTZNb0twc0R0UTR4UGZib0o2blBFVE5wMVpjeTVtVTg0dnk0Mkk2eXFLeXd5RDN1MDRTWmNGenJIZEpHdWhfV1AxNm13MkxJTVFoQjhXdFpGcGpkOTl3QjdyYklaRk5HV3hhSXJxWUw1a29BQlF4dE0tMDJUajl0akNfSURzcFRqREpvRXA3azd0NTVxY2hlOTRQbS0zeUtSYjZqanl6YjFzTDJNWXdpVHQxVzc0YlVWc25sTGZvWVRLQzk0b2JudEtMQ1VSbERBZkphbmc?oc=5","date":"2025-12-15","type":"trial","source":"GlobeNewswire","summary":"Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 - GlobeNewswire","headline":"Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNbFJkcmFUSkNpaV93RThrV2RocUlvVmZtbVQ2T3ptU0F0ZFhCdmxFajlvN1BDcVg1dWFvcUV3aTh0Vk0xMGZQaE9vMG5VaVVXOXFUU1Rpd1NXUjVVQ3dNenNFbGJOOXlRR05scU5HVk1taGREbWxRbUgwSktPMTdPSzNGSENVTFVsT1hkaUpLR3VqTTA2UDZ2aHNVVV93WmRPNEJreVAzQllfdU1pZ204RVJPR09ycG5KeTdtY0c2WVBaUXNuM1RLUTN1a0NYYjNjZm5IbGdYbXNnNDRxc2pBcFZzVGZnQlhEczFWT1VBd1dFWnMzUkk3cUFfODBYZlFjdTYyYzhTbkFQUUU?oc=5","date":"2025-06-04","type":"pipeline","source":"European Medical Journal","summary":"Drug-Coated Balloons in Percutaneous Coronary Interventions: Insights into Device Design and Translation to the Clinic - European Medical Journal","headline":"Drug-Coated Balloons in Percutaneous Coronary Interventions: Insights into Device Design and Translation to the Clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9DOUR0VW13c2Q0eHpWTzJhS0dqV0lYNlB0SHlrNHBKQTVKcl9oTDJ0UWwzS3c3S0VOSjR4QkVNcnVTQXBaSXAtSkJtcnhlMzhidFFKNDUtSGZRbk5GVkc2Wk5Tc1M1WFJ2TXA3SDV0bHh3aTg?oc=5","date":"2024-05-06","type":"pipeline","source":"American Heart Association Journals","summary":"Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PA","headline":"Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularizatio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNeEpJM05od21QTmpZN09WUDFicWoxZVZzT0kwRDQ5eE83VEpfOW82S2pvamJIMnd6Uk91d2ZzQnB4RnJFQjdkNndLNmJWdVhWMHFISE5PRjhWYmN3NlpqSXdieVVBZklBS3I5MmdzaHNPSzRSQlBVMGZXcm1qbHJzdHZsSnZIaFRtM0N2a29HSU0zaVdzZXJ6MllXZkg?oc=5","date":"2019-07-04","type":"pipeline","source":"openPR.com","summary":"Vascular Closure Device Market 2019 | Industry Insights by Top - openPR.com","headline":"Vascular Closure Device Market 2019 | Industry Insights by Top","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNSVZ5WTc1QTB0VGJGZmtTTUx2Y0duYXE1WUNOM0lIM3o2aXBiSk5JMV9oY1FhWVM3WVA4eFZTMVZibWRjc3FuOTJPZjdxanRCaGVSSzdrNmV2VVBYSVcxNEhaYWJ4THZGajZ4Zy1zOTU5NV9TbGtyZ2pUTThGQzVrRHRmZE1pSDZ5YjBtcDFXaE91QQ?oc=5","date":"2018-12-18","type":"deal","source":"dicardiology.com","summary":"Merit Medical Acquires Assets of Vascular Insights LLC - dicardiology.com","headline":"Merit Medical Acquires Assets of Vascular Insights LLC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUFp6QzI1WWc4cHRCT0g5OVFiS2JSUElrODZqb2lnOXpZbWZPUWxOc2stRUNZR1JJVjRBcDc4LXBmZ0szeWtHamFoSTJ5WE5LVjEtRVpSTmhXU0NENDh1YUtvVml4NzNFekVfOFJVR2JYdE8xbDBjY1g2a0VidG8zeWp6dHlKRWJiMC03VV9n?oc=5","date":"2018-12-18","type":"pipeline","source":"MassDevice","summary":"Merit Medical puts $60m on the table for Vascular Insights - MassDevice","headline":"Merit Medical puts $60m on the table for Vascular Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNMlUweUMyS2otOWMwbzhuNEpuc2VLc2lpTW9MVy1JQk1vYTVwUmh2eENtUlV1QVNHMTQ4MWZUX1RGS0pTM1hNeHBud3RNdEk1NmtOdVA1SW9USllteUlBRGRPSmR5T3ZBSU1KSGtVMWtyMzMyZ1l1ZGZscnBUVnJXMldJUjlib2ZLTnozUUVvYkl0NGJoTU1fS3doOGI0Z0ZzQTZSSFZtejRUeHJyLWRPYnpVZmJsc0k4MDZkdUVBVGpybkJsY1JhR1c5OTRkb3NFVUlWNnJn?oc=5","date":"2018-10-30","type":"pipeline","source":"BioSpace","summary":"Vascular Insights® Announces New Chief Executive Officer and President James (Chip) Draper To Lead The Executive Team - BioSpace","headline":"Vascular Insights® Announces New Chief Executive Officer and President James (Chip) Draper To Lead The Executive Team","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}